Nephros (NEPH) Non-Current Assets (2010 - 2026)
Nephros' (NEPH) quarterly Non-Current Assets came in at $2.3 million in Q1 2026, down 17.52% year-on-year from $2.8 million in Q1 2025, and down 4.96% quarter-over-quarter from $2.4 million in Q4 2025.
Nephros (NEPH) Non-Current Assets (2010 - 2026) Analysis & Trends
Nephros' Non-Current Assets history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 17.52% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $9.9 million, a 16.64% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 16.96% from the prior year.
- Non-Current Assets declined to $2.3 million in Q1 2026 per NEPH's latest filing, from $2.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.9 million in Q1 2022 and bottomed at $2.2 million in Q3 2022.
- The 5-year median for Non-Current Assets is $2.7 million (2022), against an average of $2.9 million.
- Across the five-year window, Non-Current Assets plunged 47.2% in 2022 and climbed 28.4% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $2.7 million in 2022, then rose by 26.22% to $3.5 million in 2023, then retreated by 15.74% to $2.9 million in 2024, then declined by 16.96% to $2.4 million in 2025, then retreated by 4.96% to $2.3 million in 2026.
- Per Business Quant, the three latest NEPH Non-Current Assets figures stand at $2.3 million (Q1 2026), $2.4 million (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 3.83 Mn |
| Mar 31, 2022 | 3.87 Mn |
| Dec 31, 2021 | 4.02 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 3.15 Mn |